ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Revenue History
Annual and quarterly revenue from 2016 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AAPG Revenue Growth
AAPG Revenue Analysis (2016–2024)
As of May 8, 2026, ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) generated trailing twelve-month (TTM) revenue of $1.29 billion, reflecting significant decline in growth of -71.6% year-over-year. The most recent quarter (Q2 2025) recorded $233.7 million in revenue, up 48.9% sequentially.
Looking at the longer-term picture, AAPG's 5-year compound annual growth rate (CAGR) stands at +132.2%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $980.6 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including ABBV (+8.6% YoY), BCAB (-81.8% YoY), and KYMR (-12.6% YoY), AAPG has underperformed the peer group in terms of revenue growth. Compare AAPG vs ABBV →
AAPG Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AAPGCurrent | $1.3B | -71.6% | +132.2% | -37.7% | |
 ABBV | $61.2B | +8.6% | +6.0% | 32.8% | |
 BCAB | $2M | -81.8% | +36.1% | -2965.3% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 ARVN | $263M | -0.3% | +58.9% | -43.8% |
AAPG Historical Revenue Data (2016–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $980.6M | +341.8% | $951.6M | 97.0% | $-369,730,000 | -37.7% |
| 2023 | $222.0M | +5.9% | $191.4M | 86.2% | $-872,636,000 | -393.1% |
| 2022 | $209.7M | +651.4% | $187.7M | 89.5% | $-849,810,000 | -405.2% |
| 2021 | $27.9M | +124.2% | $24.6M | 88.1% | $-869,835,000 | -3116.6% |
| 2020 | $12.4M | -14.2% | $10.5M | 84.2% | $-663,941,000 | -5332.9% |
| 2019 | $14.5M | +113.2% | $12.4M | 85.6% | $-582,685,000 | -4014.9% |
| 2018 | $6.8M | +7.6% | $6.8M | 100.0% | $-50,245,491 | -738.1% |
| 2017 | $6.3M | -17.5% | $6.3M | 100.0% | $-130,668,000 | -2064.9% |
| 2016 | $7.7M | - | $7.4M | 96.6% | $-114,622,000 | -1495.0% |
See AAPG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AAPG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AAPG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAAPG — Frequently Asked Questions
Quick answers to the most common questions about buying AAPG stock.
Is AAPG's revenue growth accelerating or slowing?
AAPG revenue declined -71.6% year-over-year, contrasting with the 5-year CAGR of +132.2%. TTM revenue fell to $1.3B. This reverses the prior growth trend.
What is AAPG's long-term revenue growth rate?
ASCENTAGE PHARMA GROUP INTERNATIONAL's 5-year revenue CAGR of +132.2% reflects the variable expansion pattern. Current YoY growth of -71.6% is below this long-term average.
How is AAPG's revenue distributed by segment?
AAPG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2024 are available for download. Segment mix reveals concentration and diversification trends.